Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1

摘要

Compounds of formula I and IV are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorder: wherein the variables A-B, R1, R2, m, and Q are described herein.